Podcast Episodes

Podcast: How Can Exercise Help Manage Parkinson’s?

Dr. Lisa Shulman from the University of Maryland discusses how exercise may help manage Parkinson's motor and non-motor symptoms in our latest podcas…

11 years, 4 months ago

Podcast: Parkinson’s Research Year in Review

In our latest podcast. MJFF CEO Dr. Todd Sherer discusses the progress in Parkinson's research seen this year.

Mentioned in this episode:

Researchers a…

11 years, 5 months ago

Podcast: Strategies for Stopping Parkinson’s

We say Parkinson’s disease is different for each person, but there are a couple things all people with PD share: Lewy bodies and dopamine loss.

Mentio…

11 years, 6 months ago

Podcast: What Is Dystonia?

Dystonia is the third most common movement disorder and a symptom of Parkinson's disease. Bonnie Strauss talks about her experience, and Dr. Rachel D…

11 years, 7 months ago

Podcast: Meet the Newest Member of Your Care Team: The Smartwatch

Dr. William Marks talks to Dave Iverson about how wearable devices may help people with Parkinson's monitor their disease and help researchers test n…

11 years, 9 months ago

Podcast: Six New Genetic Risk Factors for Parkinson's Identified

Scientists have found six new gene variants associated with Parkinson's, which could point to new treatment paths.

Mentioned in this episode:

Researche…

11 years, 9 months ago

Podcast: What Causes "Off" Episodes?

CEO Todd Sherer, PhD, talks to Dave Iverson about why levodopa loses efficacy over time and new therapies in development to even out on/off cycles.

Me…

11 years, 11 months ago

Podcast: Alzheimer’s and Parkinson’s, What’s the Connection?

Mark Frasier, PhD, VP of research programs at MJFF, discusses what we know about the overlap between Alzheimer's and Parkinson's diseases.

Mentioned i…

12 years ago

Podcast: How Parkinson’s Variability Could Point to Personalized Treatments

The experience of Parkinson's disease is different for each patient. Studying that variability may allow researchers to develop personalized treatmen…

12 years, 1 month ago

Podcast: Drug That May Slow Parkinson’s Progression Granted $23 Million from NIH for Phase III Testing

Tanya Simuni, MD, principal investigator of the STEADY-PD, and MJFF CEO Todd Sherer talk about the study of isradipine, recently granted $23 million …

12 years, 1 month ago